GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Basic Sciences/Adipose Tissue: Nature Reviews Endocrinology | June 2026
30

Adipose Tissue: Nature Reviews Endocrinology | June 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated June 1, 2026
  • Adipose tissue is no longer viewed simply as a fat storage organ; it is now recognized as a highly active endocrine and neuro-regulatory organ that coordinates whole-body metabolism.
  • Adipose tissue communicates through two major pathways:

Humoral signaling (hormones, metabolites, lipid mediators, cytokines, extracellular vesicles)

Neuronal signaling (sympathetic and sensory nerve networks)

  • Adipose-derived humoral factors include:

Adipokines

Lipid mediators

Metabolites

Chemokines

Exosomal microRNAs

  • These signals regulate insulin sensitivity, glucose metabolism, lipid utilization, inflammation, vascular health, and overall cardiometabolic homeostasis.
  • Sympathetic nerves provide rapid control of adipose tissue function, stimulating:

Lipolysis in white adipose tissue

Thermogenesis in brown adipose tissue

Browning of white adipose tissue

  • Sensory nerve fibers act as metabolic sensors, detecting chemical, thermal, and mechanical signals within adipose tissue and relaying information back to the central nervous system.
  • This bidirectional communication creates a sophisticated feedback system linking adipose tissue to the brain and peripheral organs.
  • Cold exposure activates thermogenic adipose tissue and induces release of specific adipokines and lipid mediators that improve systemic glucose and lipid metabolism.
  • Exercise also modifies adipose signaling networks, contributing to many of the metabolic benefits traditionally attributed solely to skeletal muscle.
  • Obesity disrupts both endocrine and neural communication within adipose tissue, resulting in:

Adipokine dysregulation

Chronic inflammation

Insulin resistance

Adipose neuropathy

  • Similar disturbances are observed in:

Type 2 diabetes

Lipodystrophy

Aging-related metabolic disorders

  • Age-related deterioration of adipose signaling may contribute to declining metabolic flexibility and increased cardiometabolic risk.
  • Emerging technologies are rapidly transforming adipose tissue research, including:

Single-cell sequencing

Multi-omics platforms

Secretome profiling

Organoid models

Optogenetics

Click chemistry

  • These tools are enabling unprecedented characterization of adipose-derived signaling molecules and neural circuits.
  • Future therapeutic opportunities may include:

Synthetic adipokine analogues

Lipid mediator–based therapies

Neural circuit modulation

Precision targeting of adipose communication pathways

  • The review places adipose tissue at the center of modern metabolic medicine, linking obesity, diabetes, cardiovascular disease, aging, and energy homeostasis through integrated endocrine and neural networks.

Bottom line: Adipose tissue functions as a sophisticated humoral–neuronal communication hub that actively regulates systemic metabolism. Understanding and manipulating these signaling networks may open new therapeutic avenues for obesity, diabetes, cardiometabolic disease, and healthy aging.

Related Q&A

31

ANGPTL3 Inhibitors Deliver Broad Lipid Lowering : Eur J Prev Cardiol | June 2026

Introduction: Despite major advances in lipid-lowering therapy, many patients continue to experience residual cardiovascular risk, particularly those with elevated triglyceride-rich lipoproteins and mixed dyslipidemia. Angiopoietin-like protein 3 (ANGPTL3)...

32

Inflammation Creates New Therapeutic Vulnerabilities in Cancer: Nature Genetics | June 2026

Cancer cells constantly adapt to inflammatory stress generated by the immune system, particularly during immune checkpoint inhibitor therapy. This study explored whether inflammatory cytokines such as interferon-γ (IFNγ),...

33

F. nucleatum Linked to Worse CRC Survival : Cancer | June 2026

Introduction: The colorectal cancer (CRC) microbiome has emerged as a key factor influencing tumor development, progression, and response to treatment. Among microbial species implicated in CRC, Fusobacterium nucleatum...

34

Inflammation Creates New Therapeutic Vulnerabilities in Cancer: Nature Genetics | June 2026

Cancer cells constantly adapt to inflammatory stress generated by the immune system, particularly during immune checkpoint inhibitor therapy. This study explored whether inflammatory cytokines such as interferon-γ (IFNγ),...

35

TLS Atlas: Turning Tumor Immune Architecture into a Clinical Biomarker: Science | May 2026

Tertiary lymphoid structures are local immune hubs within tumors, but this study shows that their mere presence is not enough; their maturation, location, and cellular organization determine biological...

36

CLDN18.2 in PDAC: KRAS and Hyperglycaemia Create a Resistance Mechanism: Gut | 2026

CLDN18.2 is emerging as a therapeutic target in gastrointestinal cancers, but its benefit in pancreatic ductal adenocarcinoma has been limited. This study identifies a key resistance mechanism: KRAS...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer